Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPRT1 | P00492 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.52 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RAD52 | P43351 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29804869 | 1.00 | HPRT1 (1.00) | HPRT1ALDH1A1HSD17B10TSHRCYP2A6 | |
| SCHEMBL30076625 | 1.00 | HPRT1 (1.00) | HPRT1ALDH1A1HSD17B10TSHRCYP2A6 | |
| SCHEMBL16107487 | 0.87 | HPRT1 (0.77) | HPRT1ALDH1A1HSD17B10TSHRCYP2A6 | |
| SCHEMBL6244226 | 0.85 | HPRT1 (0.73) | HPRT1ALDH1A1HSD17B10TSHRTDP1 | |
| SCHEMBL22142548 | 0.84 | HPRT1 (0.73) | HPRT1ALDH1A1HSD17B10TSHRCYP2A6 | |
| SCHEMBL6421361 | 0.84 | ALDH1A1 (0.73) | HPRT1ALDH1A1HSD17B10TSHRCYP2A6 | |
| SCHEMBL177977 | 0.84 | ALDH1A1 (0.73) | HPRT1ALDH1A1HSD17B10TSHRCYP2A6 | |
| SCHEMBL278672 | 0.84 | ALDH1A1 (0.73) | HPRT1ALDH1A1HSD17B10TSHRCYP2A6 | |
| SCHEMBL29366857 | 0.84 | ALDH1A1 (0.73) | HPRT1ALDH1A1HSD17B10TSHRCYP2A6 | |
| SCHEMBL30074479 | 0.84 | ALDH1A1 (0.73) | HPRT1ALDH1A1HSD17B10TSHRCYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12631612-B2 | Fluorescent dye molecules for tracer applications in subterranean formations | SAUDI ARABIAN OIL COMPANY (SA) | 2026-05-19 | — | — | US | claimed |
| US-20250084759-A1 | FLUORESCENT DYE OIL TRACER COMPOSITIONS | SAUDI ARABIAN OIL COMPANY (SA) | 2025-03-13 | — | — | US | claimed |
| US-20230399942-A1 | FLUORESCENT DYE OIL TRACER COMPOSITIONS | SAUDI ARABIAN OIL COMPANY (SA) | 2023-12-14 | — | — | US | claimed |
| US-20230183565-A1 | MANIPULATING HYDROPHILICITY AND HYDROPHOBICITY OF CONVENTIONAL DYE MOLECULES FOR TRACER APPLICATIONS | SAUDI ARABIAN OIL COMPANY (SA) | 2023-06-15 | — | — | US | claimed |
| EP-2346876-B1 | NOVEL 4BETA-AMINO PODOPHVLLOTOXIN CONGENERS AS ANTI TUMOUR ANTIBIOTICS A PROCESS FOR THE PREPARATION THEREOF | COUNCIL SCIENT IND RES (IN) | 2013-01-30 | — | — | EP | claimed |
| US-8354547-B2 | 4β-amino podophyllotoxin congeners as anti tumour antibiotics a process for the preparation thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-01-15 | — | — | US | claimed |
| US-20110213165-A1 | NOVEL 4BETA-AMINO PODOPHYLLOTOXIN CONGENERS AS ANTI TUMOUR ANTIBIOTICS A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2011-09-01 | — | — | US | claimed |
| EP-2346876-A1 | NOVEL 4BETA-AMINO PODOPHVLLOTOXIN CONGENERS AS ANTI TUMOUR ANTIBIOTICS A PROCESS FOR THE PREPARATION THEREOF | Council of Scientific & Industrial Research (IN) | 2011-07-27 | — | — | EP | claimed |
| EP-2254600-A1 | NOVEL COMPOSITIONS AND USES THEREOF | Biosuspensions Limited (GB) | 2010-12-01 | — | — | EP | claimed |
| WO-2010052733-A1 | NOVEL 4β-AMINO PODOPHVLLOTOXIN CONGENERS AS ANTI TUMOUR ANTIBIOTICS A PROCESS FOR THE PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-05-14 | — | — | WO | claimed |
| US-20090285797-A1 | USE OF INHIBITORS OF CYP2A6 FOR REGULATING NICOTINE METABOLISM | NICOGEN INC. (CA) | 2009-11-19 | — | — | US | claimed |
| WO-2009098469-A1 | NOVEL COMPOSITIONS AND USES THEREOF | BIOSUSPENSIONS LIMITED (GB) | 2009-08-13 | — | — | WO | claimed |
| WO-2009098475-A1 | STRUCTURED SURFACTANT SYSTEMS AND USES THEREOF | BIOSUSPENSIONS LIMITED (GB) | 2009-08-13 | — | — | WO | claimed |
| US-6767872-B2 | FRICTION RESISTANCE; HEAT AND WEAR RESISTANCE | THE CHARLES STARK DRAPER LABORATORY, INC. | 2004-07-27 | — | — | US | claimed |
| US-20030087771-A1 | Elastohydrodynamic and boundary lubricant and method of lubricating | THE CHARLES STARK DRAPER LABORATORY INC. | 2003-05-08 | — | — | US | claimed |
| WO-2002094969-A2 | ELASTOHYDRODYNAMIC AND BOUNDARY LUBRICANT AND METHOD OF LUBRICATING | THE CHARLES STARK DRAPER LABORATORY, INC. (US) | 2002-11-28 | — | — | WO | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-12631612-B2 | Fluorescent dye molecules for tracer applications in subterranean formations | SAUDI ARABIAN OIL COMPANY (SA) | 2026-05-19 | — | — | US | disclosed |
| US-4729950-A | AROMATIC AMINE, PEROXIDASE, OXIDIZER, 2,3-DIHYDRO-1,4-PHTHALAZINEDIONE | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1988-03-08 | — | — | US | disclosed |
| US-4299915-A | INCUBATION IN PRESENCE OF PURINE ANALOG | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1981-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12631612-B2 | Fluorescent dye molecules for tracer applications in subterranean formations | CD99, TST, TDO2 | HPRT1 4415/4885ALDH1A1 1112/4885HSD17B10 1134/4885 |
| US-20090285797-A1 | USE OF INHIBITORS OF CYP2A6 FOR REGULATING NICOTINE METABOLISM | CYP2A6, CYP2B6, CYP2D6 | HPRT1 117/4885ALDH1A1 120/4885HSD17B10 127/4885 |
| US-20110213165-A1 | NOVEL 4BETA-AMINO PODOPHYLLOTOXIN CONGENERS AS ANTI TUMOUR ANTIBIOTICS A PROCESS FOR THE PREPARATION THEREOF | EIF4B, TUBB4B, TUBB4A | HPRT1 3077/4885ALDH1A1 1724/4885HSD17B10 1855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.